Migraine showdown: which pill stops the pain faster?
NCT ID NCT05211154
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a common painkiller (diclofenac potassium) works as well as a newer migraine drug (rimegepant) for stopping migraine pain within 2 hours. About 300 adults with migraine took one of the two medicines during a single attack. The goal was to see if both offer similar relief, helping patients and doctors choose the best option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE WITH AURA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Danish Headache Center
Glostrup Municipality, 2600, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists aim to forecast migraine pain using wearable sensors and early symptoms
- New migraine sprays and tablets tested in ER for quick relief
- MRI reveals Acupuncture's brain impact in migraine sufferers
- New digital program aims to ease migraine pain without drugs
- New migraine drug shows promise in Real-World study
- Heart procedure may offer lasting migraine relief, new study hopes to prove